Wall Street Zen cut shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning,Wall Street Zen reports. Several other research analysts have also recently weighed in on ARTV. Cantor Fitzgerald restated an “overweight” rating and issued a $40.00 price objective […]

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) Director Howard Welgus sold 4,728 shares of Arcutis Biotherapeutics stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $26.93, for a total transaction of $127,325.04. Following the completion of the transaction, the director owned 35,207 shares in the company, […]